• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: ceritinib

  • ALK—Targeted Lung Cancer Drugs Benefited Real World Patients  0
    • in AJO · Audio · Oncology
    • — 7 Nov, 2018

    ALK—Targeted Lung Cancer Drugs Benefited Real World Patients 

    MUNICH— Anaplastic lymphoma kinase (ALK) inhibitors are as effective in “real world” clinical use for treating patients with non-small cell lung cancer (NSCLC) who test positive for ALK gene rearrangements as they are in clinical studies—even though randomized trials “cherry …

    Read more
    Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer 0
    • in AJO · Audio · Oncology
    • — 27 Oct, 2018

    Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer

    MUNICH—More than four years median overall survival was reported in patients treated with an inhibitor of anaplastic lymphoma kinase (ALK) for their ALK gene rearranged non-small cell lung cancer (NSCLC) in a single-arm phase two study reported at the 2018 …

    Read more
  • Second-Generation ALK Inhibitor=Longer PFS in ALK+ Lung Cancer After Crizotinib 0
    • in AJO · Audio · Oncology
    • — 8 Dec, 2016

    Second-Generation ALK Inhibitor = Longer PFS in ALK+ Lung Cancer After Crizotinib

    COPENHAGEN—Longer progression free survival (PFS) was achieved in patients with ALK-rearranged non-small cell lung cancer (NSCLC) previously treated with crizotinib randomised to treatment with the second generation anaplastic lymphoma kinase (ALK) inhibitor ceritinib rather than chemotherapy in the phase 3 …

    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: ceritinib

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.